• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA.

作者信息

Lupidi G, Cristalli G, Marmocchi F, Riva F, Grifantini M

机构信息

Department of Cell Biology, University of Camerino, Italy.

出版信息

J Enzyme Inhib. 1985;1(1):67-75. doi: 10.3109/14756368509031283.

DOI:10.3109/14756368509031283
PMID:3916912
Abstract

Deaza analogues of adenosine and EHNA were tested as inhibitors of the enzyme adenosine deaminase (ADA) obtained from several sources including human erythrocytes, calf intestine, Saccaromices cerevisiae, Escherichia coli and Takadiastase. Ki values of the inhibitors suggest differences among the enzymes both at purine and erythro-nonyl binding site. Among the ribofuranosyl derivatives, 1-deazaadenosine is the best inhibitor, its Ki ranging between 3.5 x 10(-7) and 4 x 10(-5) M for ADA from erythrocytes and Takadiastase respectively. Only ADA from erythrocytes and calf intestine bind EHNA and some of deazaEHNA analogues; 3-deazaEHNA behaves very similarly to EHNA both in affinity and slow binding mechanism, whereas 1-deazaEHNA, though less potent, is a good inhibitor.

摘要

相似文献

1
Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA.
J Enzyme Inhib. 1985;1(1):67-75. doi: 10.3109/14756368509031283.
2
Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.腺苷脱氨酶抑制剂。赤藓糖型-9-(2-羟基-3-壬基)腺嘌呤去氮类似物的合成及生物活性
J Med Chem. 1988 Feb;31(2):390-3. doi: 10.1021/jm00397a021.
3
Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.腺苷脱氨酶抑制剂。赤藓糖型-9-(2-羟基-3-壬基)腺嘌呤的脱氮类似物的合成。
J Med Chem. 1984 Mar;27(3):274-8. doi: 10.1021/jm00369a008.
4
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.腺苷脱氨酶抑制剂:赤藓糖型-9-(2-羟基-3-壬基)腺嘌呤咪唑类似物的合成及其构效关系
J Med Chem. 1991 Mar;34(3):1187-92. doi: 10.1021/jm00107a044.
5
Inhibition studies on membrane adenosine deaminase from human placenta.人胎盘膜腺苷脱氨酶的抑制研究。
Biochem Mol Biol Int. 1998 Dec;46(6):1071-80. doi: 10.1080/15216549800204622.
6
Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.赤式-9-(2-羟基-3-壬基)腺嘌呤对CBA小鼠腺苷脱氨酶抑制作用的药代动力学
Biochem Pharmacol. 1982 Feb 15;31(4):535-9. doi: 10.1016/0006-2952(82)90156-3.
7
Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.(+)-和(-)-赤藓糖-9-(2-羟基-3-壬基)腺嘌呤对小牛肠腺苷脱氨酶的抑制动力学
Biochemistry. 1992 Sep 8;31(35):8216-20. doi: 10.1021/bi00150a014.
8
Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.赤型-9-(2-羟基-3-壬基)腺嘌呤(EHNA)的手性对腺苷脱氨酶抑制作用的影响。
Biochem Pharmacol. 1982 Mar 1;31(5):879-82. doi: 10.1016/0006-2952(82)90479-8.
9
Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells.
Biochem Pharmacol. 1982 Dec 15;31(24):3955-60. doi: 10.1016/0006-2952(82)90641-4.
10
Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.赤藓红-9-(2-羟基-3-壬基)-腺嘌呤(EHNA)的镇静和脑电图作用:与脑腺苷脱氨酶抑制作用的关系。
Psychopharmacology (Berl). 1983;79(2-3):126-9. doi: 10.1007/BF00427798.

引用本文的文献

1
Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.腺苷脱氨酶抑制在心血管疾病中的治疗展望。
Molecules. 2020 Oct 12;25(20):4652. doi: 10.3390/molecules25204652.
2
Extracellular guanosine regulates extracellular adenosine levels.细胞外鸟苷调节细胞外腺苷水平。
Am J Physiol Cell Physiol. 2013 Mar 1;304(5):C406-21. doi: 10.1152/ajpcell.00212.2012. Epub 2012 Dec 12.